Skip to main content

Idexx Laboratories cash flow statement

  • IDXX · Nasdaq
  • Biotechnology
  • Health Care Equipment
  • S&P 500
$704.23+0.89%Close 13 Nov 2026 · Market value $55.66B

In fiscal 2025 (the year to 31 Dec 2025), Idexx Laboratories generated $1.18B of operating cash flow and $1.06B of free cash flow, after $124.7M of capital expenditure.

From Idexx Laboratories's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Idexx Laboratories cash flow statement, annual
USDFY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Net income$116.2M$122.2M$141.3M$161.8M$178.3M$187.8M$181.9M$192.1M$222.0M$263.1M$377.0M$427.7M$581.8M$744.8M$679.1M$845.0M$887.9M$1.06B$1.18B
Depreciation & amortization$47.98M$49.77M$45.96M$48.20M$52.41M$54.60M$58.89M$68.96M$78.22M$83.14M$83.18M$88.01M$96.00M$104.6M$111.9M$114.9M$129.9M$145.2M$158.0M
Stock-based compensation$10.50M$11.62M$13.26M$15.50M$15.95M$16.54M$18.10M$19.88M$19.89M$23.52M$25.16M$39.28M$30.95M$37.76M$49.77M$59.74M$60.30M$60.01M$64.75M
Operating cash flow$143.3M$175.0M$178.8M$217.9M$222.4M$246.0M$235.8M$221.8M$338.9M$373.3M$400.1M$459.2M$648.1M$755.5M$543.0M$906.5M$929.0M$1.18B$1.42B
Operating cash flow margin14.0%17.0%16.2%17.9%17.2%17.9%15.9%13.8%19.1%19.0%18.1%19.1%23.9%23.5%16.1%24.8%23.8%27.5%30.4%
Capital expenditures$89.97M$50.66M$38.91M$49.68M$57.62M$77.61M$60.52M$82.92M$64.79M$74.38M$115.8M$155.0M$107.0M$119.5M$148.8M$133.6M$120.9M$124.7M$115.0M
Acquisitions$3.89M$7.91M—$46.76M$2.66M$10.92M$25.11M$10.30M$1.96M$14.58M$22.50M$50.30M$1.50M$173.4M$11.51M$0.00$76.69M$0.00—
Free cash flow$53.34M$124.3M$139.9M$168.2M$164.8M$168.4M$175.3M$138.9M$274.2M$298.9M$284.3M$304.2M$541.1M$636.0M$394.1M$772.9M$808.1M$1.06B$1.30B
Free cash flow margin5.2%12.0%12.7%13.8%12.7%12.2%11.8%8.7%15.4%15.2%12.8%12.6%20.0%19.8%11.7%21.1%20.7%24.6%28.0%
Free cash flow per share$0.43$1.02$1.17$1.44$1.47$1.56$1.73$1.48$3.02$3.34$3.21$3.47$6.24$7.35$4.66$9.20$9.71$13.05$16.35
Gross share repurchases$132.3M$83.10M$143.1M$255.5M$132.3M$367.8M$618.2M$402.0M$304.1M$282.6M$369.3M$301.7M$182.8M$746.8M$819.7M$71.92M$837.0M$1.22B$1.05B
Stock issuance proceeds$16.36M$16.37M$28.86M$28.80M$24.17M$38.23M$29.44M$22.40M$38.34M$38.62M$38.20M$36.11M$51.33M$46.56M$35.75M$47.03M$44.49M$93.36M$100.4M
Net share repurchases$116.0M$66.73M$114.2M$226.7M$108.1M$329.5M$588.7M$379.6M$265.7M$243.9M$331.1M$265.6M$131.5M$700.2M$784.0M$24.89M$792.5M$1.12B$947.4M
Cash interest paid$5.08M$2.77M$2.60M$3.76M$3.94M$5.02M$12.30M$27.20M$31.80M$37.60M$34.70M$29.70M$32.40M$30.50M$40.30M$41.00M$33.80M$37.70M—
Free cash flow after SBC$42.84M$112.7M$126.7M$152.7M$148.8M$151.8M$157.2M$119.0M$254.3M$275.4M$259.2M$264.9M$510.2M$598.2M$344.4M$713.1M$747.8M$997.1M$1.24B

Quarterly

Idexx Laboratories cash flow statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Net income$194.5M$235.6M$203.3M$232.8M$216.1M$242.7M$294.0M$274.6M$248.2M$278.4M$338.4M$317.1M
Depreciation & amortization$29.74M$29.90M$32.19M$34.13M$33.71M$34.06M$35.77M$36.63M$38.72M$37.68M$41.05M$40.56M
Stock-based compensation$15.22M$14.40M$15.72M$15.92M$14.26M$14.62M$14.85M$14.43M$16.11M$16.34M$16.09M$16.22M
Operating cash flow$249.9M$198.6M$248.3M$220.1M$262.0M$238.0M$185.7M$402.3M$355.8M$266.2M$347.2M$449.7M
Operating cash flow margin27.7%20.6%24.7%22.6%27.5%23.8%16.7%36.4%32.6%23.3%28.5%37.0%
Capital expenditures$32.56M$30.27M$33.30M$28.09M$29.25M$30.03M$34.10M$31.11M$29.43M$31.98M$24.65M$28.93M
Acquisitions$0.00$77.00M$0.00$306.0K$0.00$0.00$0.00$0.00$0.00———
Free cash flow$217.3M$168.3M$215.0M$192.0M$232.8M$207.9M$151.6M$371.2M$326.3M$234.3M$322.5M$420.8M
Free cash flow margin24.1%17.5%21.4%19.7%24.4%20.8%13.7%33.6%29.9%20.5%26.5%34.7%
Free cash flow per share$2.59$2.00$2.58$2.31$2.82$2.54$1.87$4.60$4.05$2.92$4.07$5.32
Gross share repurchases$36.85M$154.8M$215.5M$220.8M$246.0M$400.9M$338.1M$240.2M$237.8M$351.0M$346.8M$112.2M
Stock issuance proceeds$11.33M$20.88M$5.36M$5.00M$13.26M$7.19M$17.33M$50.97M$17.87M$18.16M$32.91M$31.48M
Net share repurchases$25.52M$133.9M$210.2M$215.8M$232.7M$393.7M$320.8M$189.2M$219.9M$332.9M$313.9M$80.70M
Free cash flow after SBC$202.1M$153.9M$199.3M$176.1M$218.5M$193.3M$136.8M$356.8M$310.2M$217.9M$306.4M$404.6M

The main figures as JSON and plain text. See data and methodology.

IDXX in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.